1. Home
  2. KOPN vs VIGL Comparison

KOPN vs VIGL Comparison

Compare KOPN & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOPN
  • VIGL
  • Stock Information
  • Founded
  • KOPN 1984
  • VIGL 2020
  • Country
  • KOPN United States
  • VIGL United States
  • Employees
  • KOPN N/A
  • VIGL N/A
  • Industry
  • KOPN Semiconductors
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOPN Technology
  • VIGL Health Care
  • Exchange
  • KOPN Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • KOPN 282.1M
  • VIGL 89.3M
  • IPO Year
  • KOPN 1992
  • VIGL 2022
  • Fundamental
  • Price
  • KOPN $1.66
  • VIGL $2.76
  • Analyst Decision
  • KOPN Strong Buy
  • VIGL Strong Buy
  • Analyst Count
  • KOPN 4
  • VIGL 5
  • Target Price
  • KOPN $2.63
  • VIGL $21.00
  • AVG Volume (30 Days)
  • KOPN 10.9M
  • VIGL 2.7M
  • Earning Date
  • KOPN 03-13-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • KOPN N/A
  • VIGL N/A
  • EPS Growth
  • KOPN N/A
  • VIGL N/A
  • EPS
  • KOPN N/A
  • VIGL N/A
  • Revenue
  • KOPN $44,266,305.00
  • VIGL N/A
  • Revenue This Year
  • KOPN $21.20
  • VIGL N/A
  • Revenue Next Year
  • KOPN $13.55
  • VIGL N/A
  • P/E Ratio
  • KOPN N/A
  • VIGL N/A
  • Revenue Growth
  • KOPN 0.60
  • VIGL N/A
  • 52 Week Low
  • KOPN $0.56
  • VIGL $1.49
  • 52 Week High
  • KOPN $2.79
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • KOPN 51.45
  • VIGL 70.15
  • Support Level
  • KOPN $1.58
  • VIGL $2.54
  • Resistance Level
  • KOPN $1.94
  • VIGL $2.88
  • Average True Range (ATR)
  • KOPN 0.18
  • VIGL 0.22
  • MACD
  • KOPN -0.03
  • VIGL 0.03
  • Stochastic Oscillator
  • KOPN 29.79
  • VIGL 85.19

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: